Mercator MedSystems said last week that it raised $14.3 million from 25 investors as part of a $15 million equity round.
The California-based company is developing catheter-guided micro-infusion systems for non-systemic delivery of therapeutic agents across blood vessels as a treatment for peripheral artery disease.
Get the full story at our sister site, Drug Delivery Business News.